{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:54:34Z","timestamp":1792522474966,"version":"4.5.0"},"reference-count":29,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/13696998.2024.2384263","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T04:32:14Z","timestamp":1722573134000},"page":"1046-1052","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Healthcare resource utilization and costs associated with hepatitis A in the United States: a retrospective database analysis"],"prefix":"10.1080","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6176-0677","authenticated-orcid":false,"given":"Salome","family":"Samant","sequence":"first","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5333-7014","authenticated-orcid":false,"given":"Edith","family":"Chen","sequence":"additional","affiliation":[{"name":"Taiwan Tigermed Consulting Co., Ltd","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Carias","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7915-8553","authenticated-orcid":false,"given":"Stephanie A.","family":"Kujawski","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"e_1_3_4_2_1","unstructured":"Foster MA Haber P Nelson NP et\u00a0al. United States Centers for Disease Control. In: Epidemiology and Prevention of Vaccine-Preventable Diseases [Internet]; 2021 Aug 18 [cited 2022 Nov 28]. Available from: https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/chapters.html"},{"key":"e_1_3_4_3_1","unstructured":"United States Centers for Disease Control and Prevention (CDC). Hepatitis A; 2020 [updated 2020 Jun 22]. Available from: https:\/\/www.cdc.gov\/hepatitis\/hav\/index.htm"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6905a1"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7202a3"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7135a1"},{"key":"e_1_3_4_7_1","unstructured":"United States Centers for Disease Control and Prevention (CDC). 2021 National Viral Hepatitis Progress Report; 2021 [updated 2021 Jun 8]. Available from: https:\/\/www.cdc.gov\/hepatitis\/policy\/npr\/2021\/NationalProgressReport2021.htm"},{"key":"e_1_3_4_8_1","unstructured":"Centers for Disease Control and Prevention. Viral hepatitis surveillance \u2013 United States 2021; 2023 Aug [updated 2023 Aug 7]. Available from: https:\/\/www.cdc.gov\/hepatitis\/statistics\/2021surveillance\/index.htm"},{"key":"e_1_3_4_9_1","unstructured":"United States Centers for Disease Control and Prevention (CDC). Person-to-person outbreaks of hepatitis A across the United States; updated 2022 Jun 13. Available from: https:\/\/www.cdc.gov\/hepatitis\/outbreaks\/2017March-HepatitisA.htm"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7139a1"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.2166\/wh.2017.083"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.01.081"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2022.04.002"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2605.191224"},{"key":"e_1_3_4_15_1","unstructured":"United States Centers for Disease Control and Prevention (CDC). Viral hepatitis surveillance 2018 United States. 2020 Jul."},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa636"},{"key":"e_1_3_4_17_1","unstructured":"Merative. Accelerate research and discovery with machine learning in HEOR and epidemiology studies; 2023. Available from: https:\/\/www.merative.com\/documents\/brief\/accelerate-research-epidemiology"},{"key":"e_1_3_4_18_1","unstructured":"IBM Watson Health. IBM MarketScan Research Databases for Life Sciences Researchers. USA; 2021."},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1159\/000521288"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(92)90133-8"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1159\/000516599"},{"key":"e_1_3_4_22_1","unstructured":"Agency for Healthcare Research and Quality (AHRQ). Medical Expenditure Panel Survey (MEPS); 2022 [updated 2022 Apr 28]. Available from: https:\/\/meps.ahrq.gov\/about_meps\/Price_Index.shtml"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4365"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/2193-1801-2-614"},{"key":"e_1_3_4_25_1","unstructured":"Centers for Disease Control and Prevention. Surveillance for viral hepatitis \u2013 United States 2016; updated 2018 Apr 16. Available from: https:\/\/www.cdc.gov\/hepatitis\/statistics\/2016surveillance\/index.htm"},{"key":"e_1_3_4_26_1","unstructured":"Centers for Disease Control and Prevention. Notifiable infectious disease data tables updated May 16. ; 2023. Available from: https:\/\/www.cdc.gov\/nndss\/data-statistics\/infectious-tables\/index.html"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss7003a1"},{"key":"e_1_3_4_28_1","first-page":"61","article-title":"Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services","volume":"9","author":"Centers for Disease Control and Prevention","year":"2012","unstructured":"Centers for Disease Control and Prevention. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services. MMWR Recomm Rep. 2012;9:61\u201365.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.36469\/001c.87538"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2015.03.008"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2024.2384263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:48:19Z","timestamp":1772779699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2024.2384263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/13696998.2024.2384263"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2024.2384263","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-04-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}